ANTI CANCER MEDICATION
440 mg Herti Trastuzumab for Injection
Price on Request
Herti 440 mg is an injectable formulation of Trastuzumab, a targeted monoclonal antibody primarily used to treat HER2-positive breast and metastatic gastric cancers. It works by binding to HER2 proteins, thereby inhibiting cancer cell growth and promoting immune-mediated cell destruction.
liketo,usa.uk.china.southkorea.russia.japan.singapore
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Dosage Form Injection
Treatment Breast Cancer, Gastric Cancer, Metastatic Cancer, Esophageal Cancer, HER2-Positive Cancers
Packaging Type Vial
Brand Herti
Manufacturer Hetero Healthcare Limited
Strength 440 mg
Brand Name Herti
Manufactured By Hetro Healthcare
Country of Origin Made in India
Pack Size 1 injection in 1 vial
Minimum order quantity: 50 Piece
Enquire About This Product
